By
Drug Target Review2023-10-11T16:00:21
New research uncovers how neutrophils trigger cellular processes to counteract the Candida albicans toxin.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-07-08T09:00:00Z
2026-05-22T07:38:00
Contributor Dr Helen Bright, By Drug Target Review
2024-05-07T13:11:19
Sponsored by BellBrook Labs
2024-01-26T13:22:42
Sponsored by bit.bio
2023-07-11T16:13:06
Sponsored by Agilent
2023-04-04T15:03:09
Sponsored by Agilent
2025-04-22T14:58:00
Sponsored by Takara Bio USA
Site powered by Webvision Cloud